Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 1
1987 10
1988 11
1989 7
1990 15
1991 22
1992 19
1993 27
1994 41
1995 46
1996 48
1997 57
1998 56
1999 78
2000 106
2001 171
2002 164
2003 157
2004 238
2005 204
2006 243
2007 232
2008 240
2009 220
2010 275
2011 311
2012 336
2013 557
2014 852
2015 1009
2016 1209
2017 1319
2018 1411
2019 1459
2020 1576
2021 1531
2022 1497
2023 1441
2024 1428
2025 1558
2026 1268
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,736 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacoepidemiology.
Moore N, Blin P, Droz C. Moore N, et al. Handb Exp Pharmacol. 2019;260:433-451. doi: 10.1007/164_2019_318. Handb Exp Pharmacol. 2019. PMID: 31768750 Review.
Though field studies have existed for a long time, modern pharmacoepidemiology has been made possible essentially by the emergence of large population databases compiled from claims data or electronic health records. ...They rely on scrupulous analysis and execution of imp …
Though field studies have existed for a long time, modern pharmacoepidemiology has been made possible essentially by the emergence of …
Core Concepts in Pharmacoepidemiology: New-User Designs.
Her QL, Rouette J, Young JC, Webster-Clark M, Tazare J. Her QL, et al. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70048. doi: 10.1002/pds.70048. Pharmacoepidemiol Drug Saf. 2024. PMID: 39586646 Free PMC article. Review.
In this article, we review the history and key reasons for new-user comparisons in pharmacoepidemiology, highlighting the target trial framework as a unifying framework. We describe three distinct pharmacoepidemiological new-user study designs: (1) new-user versus non-user …
In this article, we review the history and key reasons for new-user comparisons in pharmacoepidemiology, highlighting the target tria …
Pharmacoepidemiology and public decision.
Zureik M, Cuenot F, Bégaud B. Zureik M, et al. Therapie. 2023 Sep-Oct;78(5):549-551. doi: 10.1016/j.therap.2023.01.001. Epub 2023 Jan 20. Therapie. 2023. PMID: 36732138 No abstract available.
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.
Gatto NM, Wang SV, Murk W, Mattox P, Brookhart MA, Bate A, Schneeweiss S, Rassen JA. Gatto NM, et al. Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1140-1152. doi: 10.1002/pds.5529. Epub 2022 Sep 9. Pharmacoepidemiol Drug Saf. 2022. PMID: 35984046 Free PMC article. Review.
This paper provides guidance on how to use visualizations throughout the life cycle of a pharmacoepidemiology study-from initial study design to final report-to facilitate rationalized and transparent decision-making about study design and implementation, and clear communi …
This paper provides guidance on how to use visualizations throughout the life cycle of a pharmacoepidemiology study-from initial stud …
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine.
Issa AM, Carleton B, Gerhard T, Filipski KK, Freedman AN, Kimmel S, Liu G, Longo C, Maitland-van der Zee AH, Sansbury L, Zhou W, Bartlett G. Issa AM, et al. Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):985-992. doi: 10.1002/pds.5226. Epub 2021 Apr 7. Pharmacoepidemiol Drug Saf. 2021. PMID: 33715268 Review.
Pharmacoepidemiology by virtue of its focus, tradition, and research orientation can provide appropriate study designs and analysis methods for precision medicine. ...We propose a new integrated multidisciplinary approach dedicated to the emerging science of precision medi …
Pharmacoepidemiology by virtue of its focus, tradition, and research orientation can provide appropriate study designs and analysis m …
Inputs of pharmacoepidemiology in addictovigilance: How do they fit together?
Soeiro T, Daveluy A, Victorri-Vigneau C, Lapeyre-Mestre M, Micallef J. Soeiro T, et al. Therapie. 2025 Mar-Apr;80(2):205-211. doi: 10.1016/j.therap.2024.10.058. Epub 2024 Oct 23. Therapie. 2025. PMID: 39516090 Free article. Review.
In this narrative review, we illustrate the inputs of pharmacoepidemiology in addictovigilance based on the experience of the French Addictovigilance Network. ...These examples show how pharmacoepidemiology fits in the multifaceted monitoring conducted by the French …
In this narrative review, we illustrate the inputs of pharmacoepidemiology in addictovigilance based on the experience of the French …
Pharmacoepidemiology in Pharmacogenetics.
Ahern TP. Ahern TP. Adv Pharmacol. 2018;83:109-130. doi: 10.1016/bs.apha.2018.04.001. Epub 2018 May 10. Adv Pharmacol. 2018. PMID: 29801572 Review.
Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives.
de Germay S, Berdaï D, Noize P. de Germay S, et al. Therapie. 2022 Mar-Apr;77(2):229-240. doi: 10.1016/j.therap.2021.08.001. Epub 2021 Nov 25. Therapie. 2022. PMID: 34973825 Review.
In parallel, post-marketing surveillance of anticancer drugs through pharmacoepidemiology has gradually developed. This paper provides (i) a detailed argumentation of the foundations for pharmacoepidemiology of anticancer drugs, (ii) an overview of pharmacoepidemiol …
In parallel, post-marketing surveillance of anticancer drugs through pharmacoepidemiology has gradually developed. This paper provide …
Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.
Caparrotta TM, Dear JW, Colhoun HM, Webb DJ. Caparrotta TM, et al. Br J Clin Pharmacol. 2019 Sep;85(9):1907-1924. doi: 10.1111/bcp.14024. Epub 2019 Jul 24. Br J Clin Pharmacol. 2019. PMID: 31206748 Free PMC article. Review.
Randomised controlled trials (RCTs) and observational studies each have advantages and disadvantages, and in both cases perceived weaknesses can be improved through modifications of design and analysis. In the field of pharmacoepidemiology, RCTs are the best way to determi …
Randomised controlled trials (RCTs) and observational studies each have advantages and disadvantages, and in both cases perceived weaknesses …
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications?
Margulis AV, Kawai AT, Anthony MS, Rivero-Ferrer E. Margulis AV, et al. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):61-71. doi: 10.1002/pds.5353. Epub 2021 Sep 29. Pharmacoepidemiol Drug Saf. 2022. PMID: 34498338 Review.
We identified key methodological elements necessary for fully understanding perinatal pharmacoepidemiology research and quantified the proportion of studies that reported these elements in a sample of publications. ...CONCLUSIONS: In this sample of pregnancy-related pha …
We identified key methodological elements necessary for fully understanding perinatal pharmacoepidemiology research and quantified th …
18,736 results
You have reached the last available page of results. Please see the User Guide for more information.